HURA

TuHURA Biosciences Inc.

TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference PR...

Citizens Jmp initiated coverage on shares of TuHURA Biosciences in a report on Monday. They issued an "outperform" rating and a $9.00 price objective for the company...

Wall Street Zen lowered shares of TuHURA Biosciences from a "hold" rating to a "sell" rating in a report on Saturday...

TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028 TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028 PR Newswire TAMPA, Fla., April 22, 2026 Credit...

Shares of TuHURA Biosciences, Inc. (NASDAQ:HURA - Get Free Report) have received an average recommendation of "Moderate Buy" from the four analysts that are presently covering the stock, Marketbeat...

Wall Street Zen upgraded TuHURA Biosciences from a "sell" rating to a "hold" rating in a research report on Wednesday...

TuHURA Biosciences, Inc. (NASDAQ:HURA - Free Report) - Equities researchers at Brookline Capital Markets issued their Q1 2026 earnings per share estimates for TuHURA Biosciences in a research note issued on Thursday, April 9th. Brookline Capital Markets analyst K. Raja forecasts that the company wil...

TuHURA Biosciences, Inc. (NASDAQ:HURA - Free Report) - Equities research analysts at Brookline Capital Markets upped their FY2029 earnings per share (EPS) estimates for shares of TuHURA Biosciences...

TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations PR Newswire TAMPA, Fla., April 7, 2026 Mrs. Garofalo brings over 20 years of experience in Phase I-IV...